As<unk>  is currently under development, this specific branch of contrast-enhanced ultrasound is not currently used in clinical settings. The majority of the previous work using<unk>  has studied angiogenesis in animal models for research purposes. Though the FDA has only approved contrast-enhanced ultrasound use in one clinical application in the United States, echocardiography, the broader technique has been used throughout Europe and Asia to great success in a variety of clinical applications. To learn more, see the current applications of contrast enhanced ultrasound. Currently investigated clinical uses The only use of<unk>  that has been investigated in clinical settings to date studied angiogenesis in the peripheral vasculature of human breast tissue. This study investigated if<unk>  could be used to reduce the need for biopsy of breast tissue when diagnosing if lesions in breast tissue were cancerous or not. Using<unk> , the authors collected and reconstructed the 3D volumes associated with vasculature surrounding lesions in the breast. These reconstructed volumes were then analyzed for vascular density and tortuosity. This information is useful for diagnosis as it has been shown that when these two factors increase in the vasculature surrounding a lesion, there is an increased risk that the lesion is cancerous.
Acoustic angiography
Narrow-band imaging
Laser Doppler imaging
Digital variance angiography
Terahertz tomography
Iatrochemistry
Microangiography
Laser speckle contrast imaging